Graham Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$879K Sell
11,129
-1,936
-15% -$165K 0.02% 543
2026
Q1
$1.13M Buy
+13,065
New +$1.17M 0.03% 405
2023
Q4
– Sell
-30,224
Closed -$1.5M – 1117
2023
Q3
$1.5M Buy
+30,224
New +$1.69M 0.04% 260
2023
Q2
– Sell
-17,994
Closed -$1.02M – 1093
2023
Q1
$1.02M Buy
+17,994
New +$1.15M 0.03% 500
2022
Q4
– Sell
-5,218
Closed -$310K – 1138
2022
Q3
$310K Buy
+5,218
New +$314K 0.01% 892
2022
Q2
– Sell
-5,098
Closed -$376K – 1100
2022
Q1
$376K Buy
+5,098
New +$354K 0.01% 651

Other funds holding GMED

Graham Capital Management's GMED Position: Q2 2026 in Review

Graham Capital Management reduced its Globus Medical (GMED) stake by 15% in Q2 2026, selling an estimated $165K and leaving 11,129 shares worth $879K. The position accounts for 0.02% of the portfolio, ranked #543.

Graham Capital Management first reported a position in GMED in Q1 2022 and has held it in 6 quarters since. The position peaked at $1.5M in Q3 2023. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Graham Capital Management held 11,129 shares of Globus Medical worth $879K as of Q2 2026.
  • Graham Capital Management sold 1,936 Globus Medical shares in Q2 2026, an estimated $165K.
  • Globus Medical made up 0.02% of Graham Capital Management's portfolio in Q2 2026, its #543 holding.
  • Graham Capital Management first reported a position in Globus Medical in Q1 2022 and has held it in 6 quarters since.
  • Graham Capital Management's Globus Medical position peaked at $1.5M in Q3 2023.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.